Skip to main content
. Author manuscript; available in PMC: 2023 Feb 22.
Published in final edited form as: Nat Med. 2022 Dec 7;29(2):376–383. doi: 10.1038/s41591-022-02120-7

Extended Data Table 7.

Hypoglycaemia by hypothesised drug/strata combinations. Proportions experiencing hypoglycaemia for each of the hypothesised drug/strata combinations.

Hypothesis 1 Pioglitazone Sitagliptin
BMI>30kg/m2 33/263 (12.5%) 28/272 (10.3%)
BMI<=30kg/m2 17/185 (9.2%) 16/182 (8.8%)
Hypothesis 2 Sitagliptin Canagliflozin
eGFR 60-90 17/220 (7.7%) 12/221 (5.4%)
eGFR>90 27/234 (11.5%) 17/246 (6.9%)